Suppr超能文献

蛋白激酶Cδ(PKCδ)磷酸化是转化生长因子-β1(TGF-β1)诱导衰老过程中糖原合成酶激酶3(GSK3)失活介导的活性氧(ROS)生成的上游事件。

PKCδ phosphorylation is an upstream event of GSK3 inactivation-mediated ROS generation in TGF-β1-induced senescence.

作者信息

Byun H-O, Jung H-J, Kim M-J, Yoon G

机构信息

Department of Biochemistry & Molecular Biology, Ajou University School of Medicine , Suwon , Republic of Korea.

出版信息

Free Radic Res. 2014 Sep;48(9):1100-8. doi: 10.3109/10715762.2014.929120. Epub 2014 Jul 21.

Abstract

Transforming growth factor β1 (TGF-β1) induces Mv1Lu cell senescence through inactivating glycogen synthase kinase 3 (GSK3), thereby inactivating complex IV and increasing intracellular ROS. In the present study, we identified protein kinase C delta (PKCδ) as an upstream regulator of GSK3 inactivation in this mechanism of TGF-β1-induced senescence. When Mv1Lu cells were exposed to TGF-β1, PKCδ phosphorylation simultaneously increased with GSK3 phosphorylation, and then AKT and ERK were phosphorylated. AKT phosphorylation and Smad signaling were independent of GSK3 phosphorylation, but ERK phosphorylation was downstream of GSK3 inactivation. TGF-β1-triggered GSK3 phosphorylation was blocked by inhibition of PKCδ, using its pharmacological inhibitor, Rottlerin, or overexpression of a dominant negative PKCδ mutant, but GSK3 inhibition with SB415286 did not alter PKCδ phosphorylation. Activation of PKCδ by PMA delayed cell growth and increased intracellular ROS level, but did not induce senescent phenotypes. In addition, overexpression of wild type or a constitutively active PKCδ mutant was enough to delay cell growth and decrease the mitochondrial oxygen consumption rate and complex IV activity, but weakly induce senescence. However, PMA treatment on Mv1Lu cells, which overexpress wild type and constitutively active PKCδ mutants, effectively induced senescence. These results indicate that PKCδ plays a key role in TGF-β1-induced senescence of Mv1Lu cells through the phosphorylation of GSK3, thereby triggering mitochondrial complex IV dysfunction and intracellular ROS generation.

摘要

转化生长因子β1(TGF-β1)通过使糖原合酶激酶3(GSK3)失活来诱导Mv1Lu细胞衰老,从而使复合物IV失活并增加细胞内活性氧(ROS)。在本研究中,我们确定蛋白激酶Cδ(PKCδ)是TGF-β1诱导衰老这一机制中GSK3失活的上游调节因子。当Mv1Lu细胞暴露于TGF-β1时,PKCδ磷酸化与GSK3磷酸化同时增加,随后AKT和ERK被磷酸化。AKT磷酸化和Smad信号传导独立于GSK3磷酸化,但ERK磷酸化是GSK3失活的下游事件。使用其药理学抑制剂rottlerin抑制PKCδ或过表达显性负性PKCδ突变体可阻断TGF-β1触发的GSK3磷酸化,但用SB415286抑制GSK3并不会改变PKCδ磷酸化。佛波酯(PMA)激活PKCδ会延迟细胞生长并增加细胞内ROS水平,但不会诱导衰老表型。此外,野生型或组成型活性PKCδ突变体的过表达足以延迟细胞生长并降低线粒体氧消耗率和复合物IV活性,但弱诱导衰老。然而,对过表达野生型和组成型活性PKCδ突变体的Mv1Lu细胞进行PMA处理可有效诱导衰老。这些结果表明,PKCδ通过GSK3磷酸化在TGF-β1诱导的Mv1Lu细胞衰老中起关键作用,从而触发线粒体复合物IV功能障碍和细胞内ROS生成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验